Odence-Ford Marion bought OPRX
August 20, 2026 · Form 4 insider transaction
Odence-Ford Marion bought 57,600 shares of OptimizeRx Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
57,600
Price
$0.00
Total value
N/A
InsiderOdence-Ford Marion
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateAugust 20, 2026
Filing dateAugust 24, 2026
Shares owned after148,007
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 20, 2027, which is the first anniversary of the grant date.